Mano laboratorija - Company finances
|
EUR
|
2024
From: 2024-07-26
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|
|
Financial data
|
||
| Sales revenue | 32,438 | 117,595 |
| Profit before tax | 14,744 | 31,587 |
| Net profit | 12,532 | 26,533 |
| Equity | 12,632 | 25,341 |
| Liabilities | 17,212 | 9,264 |
| Non-current assets | 0 | 4,004 |
| Current assets | 29,844 | 30,601 |
| Total assets | 29,844 | 34,605 |
|
Taxes paid
|
||
| STI taxes | - | 4,619 |
|
Financial indicators
|
||
| Revenue change y/y | - | +262.5% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 42.0% | 76.7% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 99.2% | 104.7% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 38.6% | 22.6% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 45.5% | 26.9% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 1.4 | 0.4 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | 88,198 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Mano laboratorija - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-01-21 | 2026-01-29 | 71.63 |
| 2026-01-16 | 2026-01-20 | 70.96 |
| 2025-12-16 | 2025-12-16 | 73.34 |
| 2025-11-18 | 2025-12-08 | 73.34 |
| 2025-10-23 | 2025-11-09 | 33.84 |
| 2025-10-16 | 2025-10-22 | 33.64 |
| 2025-09-16 | 2025-09-17 | 26.33 |
| 2025-09-07 | 2025-09-14 | 26.33 |
| 2025-08-31 | 2025-09-03 | 26.33 |
| 2025-08-19 | 2025-08-29 | 26.33 |
Mano laboratorija - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Mano laboratorija, MB (code 306962502) is a Lithuanian small partnership engaged in the manufacture of other medical and dental devices, instruments and supplies. In 2025, the latest financial year, revenue reached €117.6K and net profit was €26.5K, resulting in a 22.6% profit margin. This followed 2024 revenue of €32.4K and net profit of €12.5K, although the 2024 figures cover only 158 days, so the year-on-year increase should be interpreted in that context. The company’s balance sheet strengthened during 2025: total assets increased to €34.6K, equity to €25.3K, and liabilities declined to €9.3K. Equity accounted for 73.2% of assets, and debt-to-equity stood at 0.37, indicating a conservative capital structure. Asset turnover was 3.40x, showing relatively high sales generation from a modest asset base. Revenue per employee was €117.6K, with profit per employee of €26.5K, pointing to strong productivity for a small business.